Literature DB >> 20619340

Disruption of central nervous system barriers in multiple sclerosis.

Jorge Ivan Alvarez1, Romain Cayrol, Alexandre Prat.   

Abstract

The delicate microenvironment of the central nervous system (CNS) is protected by the blood-brain barrier (BBB) and the blood-cerebrospinal fluid barrier (BCB). These barriers function in distinct CNS compartments and their anatomical basis lay on the junctional proteins present in endothelial cells for the BBB and in the choroidal epithelium for the BCB. During neuroinflammatory conditions like multiple sclerosis (MS) and its murine model experimental autoimmune encephalomyelitis (EAE), activation or damage of the various cellular components of these barriers facilitate leukocyte infiltration leading to oligodendrocyte death, axonal damage, demyelination and lesion development. This manuscript will review in detail the features of these barriers under physiological and pathological conditions, particularly when focal immune activation promotes the loss of the BBB and BCB phenotype, the upregulation of cell adhesion molecules (CAMs) and the recruitment of immune cells. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20619340     DOI: 10.1016/j.bbadis.2010.06.017

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  132 in total

Review 1.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders.

Authors:  Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2011-11-03       Impact factor: 34.870

Review 2.  Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.

Authors:  Juan M Saavedra; Enrique Sánchez-Lemus; Julius Benicky
Journal:  Psychoneuroendocrinology       Date:  2010-10-29       Impact factor: 4.905

Review 3.  The innate immune system in demyelinating disease.

Authors:  Lior Mayo; Francisco J Quintana; Howard L Weiner
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 4.  Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models.

Authors:  Yukio Takeshita; Richard M Ransohoff
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 5.  Glial regulation of the blood-brain barrier in health and disease.

Authors:  Bieke Broux; Elizabeth Gowing; Alexandre Prat
Journal:  Semin Immunopathol       Date:  2015-08-06       Impact factor: 9.623

6.  Two cases of multiple sclerosis manifesting after in vitro fertilization procedures.

Authors:  Anne Ladwig; Veronika Dunkl; Nils Richter; Michael Schroeter
Journal:  J Neurol       Date:  2016-02-17       Impact factor: 4.849

Review 7.  Overcoming the blood-brain barrier in chemotherapy treatment of pediatric brain tumors.

Authors:  Linfeng Wu; Xiaoxun Li; Dileep R Janagam; Tao L Lowe
Journal:  Pharm Res       Date:  2013-08-31       Impact factor: 4.200

8.  An in vitro blood-brain barrier model combining shear stress and endothelial cell/astrocyte co-culture.

Authors:  Yukio Takeshita; Birgit Obermeier; Anne Cotleur; Yasuteru Sano; Takashi Kanda; Richard M Ransohoff
Journal:  J Neurosci Methods       Date:  2014-05-22       Impact factor: 2.390

9.  Exacerbation of autoimmune neuroinflammation by dietary sodium is genetically controlled and sex specific.

Authors:  Dimitry N Krementsov; Laure K Case; William F Hickey; Cory Teuscher
Journal:  FASEB J       Date:  2015-04-27       Impact factor: 5.191

10.  Initial investigation of the blood-brain barrier in MS lesions at 7 tesla.

Authors:  María I Gaitán; Pascal Sati; Souheil J Inati; Daniel S Reich
Journal:  Mult Scler       Date:  2012-12-17       Impact factor: 6.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.